CLINICAL_TRIALS
research
· 2026-01-22
Clinical Trial Update: High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m) [NA]
Summary
A completed clinical trial from the University of Zurich evaluated sleep-disordered breathing in people with high-altitude pulmonary hypertension by comparing a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Zurich | Conditions: High Altitude Pulmonary Hypertension | NA | Status: COMPLETED